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Case Report
Anaesthetic management of a pregnant patient for Aortic valve replacement
Khalid M. Siddiqui, Fazal H. Khan
Department of Anaesthesia, Aga Khan University Hospital, Karachi.
Abstract
Cardiac disease can be encountered during
pregnancy with the frequency being 1% to 2% of all
pregnant women. Because of the high foetal and relative
maternal mortality during surgery, medical management is
the first line of treatment. Nevertheless, when medical
treatment fails, cardiac surgery becomes necessary. We
present the anaesthetic management of a case of Aortic
valve disease in a pregnant woman undergoing surgery. 
Case Report
A 25-year-old woman gravida III para II had history
of breathlessness since 3-4years. She noticed shortness of
breath and dyspnea on exertion at 20 weeks gestation. She
also complained of dizziness and fainting one month back.
On her antenatal checkup she was found to have a grade 3
systolic murmur. Echocardiography showed calcified aortic
valve with ventricular movement, and mild symptomatic
hypertrophied normal sized left ventricle. She was referred
to the cardiothoracic surgeon who decided for aortic valve
replacement. Grade III dyspnea was found on pre operative
evaluation. Obstetrical examination revealed positive foetal
viability. Poor foetal outcome was feared due to non pulstile
flow during cardio pulmonary bypass. Patient was prepared
for the surgery. Aspiration prophylaxis along with
antibiotics were given prior to the procedure. 
During the surgery, routine monitors were applied,
and a 14G cannula inserted in the right hand under local
anaesthesia. Invasive arterial line using Seldinger's
technique was also placed. Rapid sequence induction was
done with injection fentanyl 7µg/kg body weight, thiopental
sodium 3mg/kg body weight and rocuronium 0.9mg/kg
body weight. Air way was secured by size 7.5mm
endotracheal tube (ETT) which was confirmed by end tidal
carbon dioxide and chest auscultation. Swan ganz catheter
from right internal jugular vein for haemodynamics and
fluid management was placed after induction along with
extra 14G cannula in right hand.
Aortic valve replacement was done using cardio
pulmonary bypass with non pulstile blood flow using
membrane oxygenator and blood cardioplegia. The patient
was cooled to 30° centigrade during the procedure.
Anaesthesia was maintained with propofol infusion at the
rate of 2mg/kg/hr. Mean arterial pressure was maintained
between 50-60 mmHg during cardio pulmonary bypass with
a pump flow of 2.5 liters/min. After completion of surgery
patient was weaned off the cardio-pulmonary bypass.
Patient remained haemodynamically stable. After surgery
the obstetrician performed the foetal examination for
viability, there was obvious heart sound which was
confirmed by cardio tocho graph (CTG). The patient was
shifted to cardiac intensive care unit. Extubation was done
on the next day of surgery. Patient was shifted to the ward
and discharged, on the 5th postoperative day.
At 37th week of pregnancy she was admitted again
for elective Caesarean section, under general anaesthesia. A
healthy baby boy weighing 2.9 kg with Apgar score of 8 and
9 was delivered.
Discussion
The incidence of maternal heart disease during
pregnancy has been estimated to be 1.5%1. Most of the
pregnant women with heart ailments seen at referral centers
are those with congenital heart disease. The next largest
group includes women with rheumatic heart disease2. Aortic
stenosis is infrequently encountered during pregnancy and
is usually due to a congenitally abnormal valve. Patients
with mild aortic stenosis usually tolerate pregnancy well.
Patients with moderate or severe aortic stenosis are very
sensitive to preload changes and hypotension. They are
unable to augment cardiac output (Co), with increase in LV
systolic and filling pressures leading to heart failure and
ischemia. Cardiac surgery during pregnancy has played a
limited but defined role alongside the accepted medical
management in the overall care of the patient. Maternal
mortality associated with cardiac surgery varies from 1.5%
to 4.2%, compared with the foetal mortality rate of 9.5% to
33%4.
There are now many reports of foetal survival to
term after corrective surgery performed in the second or
third trimesters4. The main goal in the management of these
patients is to prevent further derangement of cardiac
function during surgery and labour in a heart which is
already stressed by the "physiological" changes of
pregnancy. This can be accomplished by effective
anxiolysis, analgesia and anaesthesia. Ultimately, the aim of
any anaesthetic intervention is to ensure the well being of
both the mother and the foetus. When cardiac surgery is
performed during pregnancy, foetal mortality is 20-35%. It
is the additional cardiac burden associated with pregnancy
that often causes heart disease to show itself at this time.
When surgery is needed, timing is of key importance for the
welfare of the foetus. During the first trimester, any injury
to the foetus, whether due to drugs, hypoxia or changes in
blood flow, has a high probability of causing congenital
defects and spontaneous abortion. The third trimester is a
time of low risk for the foetus, especially beyond 28 weeks,
because if labour is precipitated by surgery, there is a good
chance that the baby will survive in a neonatal unit, and the
foetus is more resilient during cardiopulmonary bypass at
this stage. However, by the third trimester, a gravid woman
requiring surgery for a cardiac defect, will have a higher risk
because of the extra cardiac output. In the second trimester
the risk is similar to a non-pregnant woman, along with a
lower risk for premature labour5.
There is always a concern on the effects of
anaesthetic agents on foetal development and teratogenicity,
especially during the first trimester. It has been evidenced
that most anaesthetic agents, intravenous, inhalatory, and
paralyzing agents are devoid of teratogenic effects and can
be safely employed in a pregnant patient6. Drugs that are
known to be safe, or do not cross the placenta, should be
used. Vasoconstrictors are avoided due to the effect on the
uterine spiral arteries. 
Hypocarbia as a result of mechanical
hyperventilation decreases the uterine blood flow by 25%,
although the blood pressure remains unchanged during
hyperventilation. The adverse effect on uterine blood flow is
attributed to a decrease in venous return and cardiac
output7,8.
The dangers of CPB include changes in coagulation,
alteration in the function of cellular and protein components
of the blood, release of vasoactive substances from
leukocytes complement activation, particulate and air
embolism, non pulsatile flow, hypothermia and
hypotension.7 All these factors can compromise the delicate
biological equilibrium between the foetus and the placenta.
There are only few studies regarding the effects of maternal
CPB on the foetus. Since the first report of the use of foetal
heart recording during bypass by Koh and Co-workers9 in
1975, it has been known that foetal bradycardia occurs
almost invariably at the onset of maternal CPB. What
causes bradycardia at the beginning of the bypass is
unknown, but it may be related to decreased foetal
oxygenation secondary to placental hypotension or to acid
base changes. 
The changes in foetoplacental perfusion during
cardiopulmonary bypass are poorly understood, despite new
methods for monitoring flow in the uterine artery, ductus
venosus and foetal aorta. It is known that hypothermia can
cause foetal hypoxia and that rewarming can likewise cause
hypoxia by inducing uterine contractions. There are only a
few reports of surgery with circulatory arrest and deep
hypothermia, and in all of these the foetus died
postoperatively. During cardiopulmonary bypass,
haemodilution, lack of pulsatile flow, uterine arterial spasm
and particulate microemboli may all alter placental
perfusion and contribute to foetal hypoxia. With pulsatile
perfusion during cardiopulmonary bypass, the hazard of
vasoconstriction in placental vessels, including spiral
arteries, is believed to be lessened by release of nitric oxide.
Thus; in pregnancy cardiopulmonary bypass is best
conducted with mild hypothermia, pulsatile perfusion, high
flow rates and minimal haemodilution.10,11
Conclusion
Cardiac surgery during pregnancy can be performed
safely by using cardiopulmonary bypass. Maternal risks are
related to the specific procedure performed. A high risk of
foetal morbidity and mortality is associated with CPB
during pregnancy. Foetal bradycardia and increased uterine
contractions need immediate attention and management.
With the optimal care provided by the modern neonatal care
units and considering caesarian section as an option, the
deleterious effects of CPB can be avoided when the
gestational age is above 28 weeks.
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